Literature DB >> 12023501

Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges.

Cari L Miller1, Mark Tyndall, Patricia Spittal, Kathy Li, Anita Palepu, Martin T Schechter.   

Abstract

Needle-exchange programs (NEPs) have been shown to be effective in reducing harm related to injection drug use and to act as an important link between the injection drug using community and preventive/treatment services. Different needle-exchange distribution methods may reach different subpopulations of injecting drug users (IDUs). We undertook this study to characterize risk behaviors by primary source of clean needles accessed by IDUs in a city with pharmacy access and fixed and mobile exchange programs. We hypothesized there would be a gradient of risk across the three types of distribution. Data were collected from within the Vancouver Injection Drug Users Study (VIDUS), a prospective cohort study. Participants who primarily obtained clean needles from pharmacies, fixed sites, or mobile exchange vans were compared using the Cochran-Armitage trend test to test for trends in increasing risk behaviors across the three types of distribution. Ordinal multivariate regression was used to adjust the associations for potential confounders. Results illustrate clear trends for increasing risk profiles from pharmacy to fixed site to mobile exchange vans. Van users were generally at higher risk than fixed-site and pharmacy users. Independent predictors of van use were fewer years injecting, difficulty finding needles, Aboriginal ethnicity, incarceration in the previous 6 months, and injecting cocaine daily. An important component of needle-exchange programs is outreach to access those who are at highest risk. Use of distribution beyond fixed sites will improve such outreach, thereby increasing program effectiveness and further preventing the transmission of blood-borne infections.

Entities:  

Mesh:

Year:  2002        PMID: 12023501      PMCID: PMC3456805          DOI: 10.1093/jurban/79.2.257

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  35 in total

1.  Injection drug use and despair through the lens of gender.

Authors:  P M Spittal; M T Schechter
Journal:  CMAJ       Date:  2001-03-20       Impact factor: 8.262

2.  Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak.

Authors:  M T Schechter; S A Strathdee; P G Cornelisse; S Currie; D M Patrick; M L Rekart; M V O'Shaughnessy
Journal:  AIDS       Date:  1999-04-16       Impact factor: 4.177

Review 3.  Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users.

Authors:  D R Gibson; N M Flynn; D Perales
Journal:  AIDS       Date:  2001-07-27       Impact factor: 4.177

4.  Can hepatitis C transmission be reduced in Australian prisons?

Authors:  K A Dolan
Journal:  Med J Aust       Date:  2001-04-16       Impact factor: 7.738

5.  "For God's sake, don't show this letter to the president...".

Authors:  A R Moss
Journal:  Am J Public Health       Date:  2000-09       Impact factor: 9.308

6.  Charting the epidemic: the case study of HIV screening of injecting drug users in San Francisco, 1985-1990.

Authors:  A R Moss; K Vranizan
Journal:  Br J Addict       Date:  1992-03

7.  Cocaine use and HIV infection in intravenous drug users in San Francisco.

Authors:  R E Chaisson; P Bacchetti; D Osmond; B Brodie; M A Sande; A R Moss
Journal:  JAMA       Date:  1989-01-27       Impact factor: 56.272

8.  Comparing new participants of a mobile versus a pharmacy-based needle exchange program.

Authors:  E D Riley; M Safaeian; S A Strathdee; M A Marx; S Huettner; P Beilenson; D Vlahov
Journal:  J Acquir Immune Defic Syndr       Date:  2000-05-01       Impact factor: 3.731

9.  Research, politics, and needle exchange.

Authors:  D C Des Jarlais
Journal:  Am J Public Health       Date:  2000-09       Impact factor: 9.308

10.  Needle-exchange attendance and health care utilization promote entry into detoxification.

Authors:  S A Strathdee; D D Celentano; N Shah; C Lyles; V A Stambolis; G Macalino; K Nelson; D Vlahov
Journal:  J Urban Health       Date:  1999-12       Impact factor: 3.671

View more
  18 in total

1.  Behavioural, social and structural-level risk factors for developing AIDS among HIV-positive people who use injection drugs in a Canadian setting, 1996-2017.

Authors:  S Ickowicz; H Dong; L Ti; S Nolan; N Fairbairn; R Barrios; M-J Milloy
Journal:  AIDS Care       Date:  2020-05-31

2.  Screening injecting drug users for sexually transmitted infections and blood borne viruses using street outreach and self collected sampling.

Authors:  C S Bradshaw; L I Pierce; S N Tabrizi; C K Fairley; S M Garland
Journal:  Sex Transm Infect       Date:  2005-02       Impact factor: 3.519

Review 3.  The role of prevention strategies in achieving HCV elimination in Canada: what are the remaining challenges?

Authors:  Stine Bordier Høj; Nanor Minoyan; Andreea Adelina Artenie; Jason Grebely; Julie Bruneau
Journal:  Can Liver J       Date:  2018-07-17

4.  An external evaluation of a peer-run "unsanctioned" syringe exchange program.

Authors:  Evan Wood; Thomas Kerr; Patricia M Spittal; William Small; Mark W Tyndall; Michael V O'Shaughnessy; Martin T Schechter
Journal:  J Urban Health       Date:  2003-09       Impact factor: 3.671

5.  Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, Estonia.

Authors:  Sigrid Vorobjov; Anneli Uusküla; Katri Abel-Ollo; Ave Talu; Don Des Jarlais
Journal:  J Urban Health       Date:  2009-11-18       Impact factor: 3.671

6.  The impact of needle-exchange programs on the spread of HIV among injection drug users: a simulation study.

Authors:  J M Raboud; M C Boily; J Rajeswaran; M V O'Shaughnessy; M T Schechter
Journal:  J Urban Health       Date:  2003-06       Impact factor: 3.671

7.  A cross-national analysis of the effects of methadone maintenance and needle and syringe program implementation on incidence rates of HIV in Europe from 1995 to 2011.

Authors:  Phillip L Marotta; Charlotte A McCullagh
Journal:  Int J Drug Policy       Date:  2016-02-26

8.  HIV prevalence among aboriginal British Columbians.

Authors:  Robert S Hogg; Steffanie Strathdee; Thomas Kerr; Evan Wood; Robert Remis
Journal:  Harm Reduct J       Date:  2005-12-24

9.  A randomized controlled trial to assess the efficacy of an interactive mobile messaging intervention for underserved smokers: Project ACTION.

Authors:  Damon J Vidrine; Faith E Fletcher; Heather E Danysh; Salma Marani; Jennifer Irvin Vidrine; Scott B Cantor; Alexander V Prokhorov
Journal:  BMC Public Health       Date:  2012-08-25       Impact factor: 3.295

10.  Assessing the role of syringe dispensing machines and mobile van outlets in reaching hard-to-reach and high-risk groups of injecting drug users (IDUs): a review.

Authors:  Md Mofizul Islam; Katherine M Conigrave
Journal:  Harm Reduct J       Date:  2007-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.